These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Antihypertensive effect of low calcium dialysis. Katzir Z, Michlin A, Boaz M, Biro A, Smetana S. Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992 [Abstract] [Full Text] [Related]
17. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K. Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280 [Abstract] [Full Text] [Related]
18. Epidemiology of arterial hypertension in renal transplant patients: changes over the last decade. Campistol JM, Romero R, Paul J, Gutiérrez-Dalmau A. Nephrol Dial Transplant; 2004 Jun; 19 Suppl 3():iii62-6. PubMed ID: 15192139 [Abstract] [Full Text] [Related]
19. [Hypertension in hemodialysis: prevalence and associated factors in Catalonia. The PRESDIAL study]. Poch E, Martinez X, Rodrigo JA, Tovar JL, Investigadores del Estudio PRESIDIAL de la Sociedad Catalana de Nefrología. Nefrologia; 2006 Jun; 26(5):564-72. PubMed ID: 17117899 [Abstract] [Full Text] [Related]
20. Queen Mary Utilization of Antihypertensive Drugs Study: side-effects of antihypertensive drugs. Cheung BM, Wong YL, Lau CP. J Clin Pharm Ther; 2005 Aug; 30(4):391-9. PubMed ID: 15985053 [Abstract] [Full Text] [Related] Page: [Next] [New Search]